Does ATEZOLIZUMAB Cause Neoplasm malignant? 214 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 214 reports of Neoplasm malignant have been filed in association with ATEZOLIZUMAB (Tecentriq Hybreza). This represents 0.6% of all adverse event reports for ATEZOLIZUMAB.
214
Reports of Neoplasm malignant with ATEZOLIZUMAB
0.6%
of all ATEZOLIZUMAB reports
194
Deaths
15
Hospitalizations
How Dangerous Is Neoplasm malignant From ATEZOLIZUMAB?
Of the 214 reports, 194 (90.7%) resulted in death, 15 (7.0%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATEZOLIZUMAB. However, 214 reports have been filed with the FAERS database.
What Other Side Effects Does ATEZOLIZUMAB Cause?
Death (3,591)
Off label use (2,340)
Disease progression (1,828)
Pyrexia (1,599)
Diarrhoea (1,490)
Fatigue (1,253)
Anaemia (1,195)
Pneumonia (1,036)
Nausea (953)
Dyspnoea (938)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which ATEZOLIZUMAB Alternatives Have Lower Neoplasm malignant Risk?
ATEZOLIZUMAB vs ATLANTIC SALMON OIL
ATEZOLIZUMAB vs ATOGEPANT
ATEZOLIZUMAB vs ATOMOXETINE
ATEZOLIZUMAB vs ATOMOXETINE\ATOMOXETINE
ATEZOLIZUMAB vs ATORVASTATIN